Shaping Your Future Health
Proudly Made in Singapore
Our Mission
Cell ID strives to provide Fast, Accurate, Affordable and Mass-Deployable solutions integrating engineering with biological sciences. We challenge traditional lab bounded diagnostics with Point-Of-Care (POC) solutions. Our aim is to free limited lab resources and bring diagnosis closer to users.
Established in 2014, Cell ID Pte. Ltd. is a Singapore-incorporated med-tech company that designs, researchs, develops and manufactures diagnostic tests. The company focuses in near-field Point-of-Care (nf-POC) and decentralised molecular diagnostic platform technologies.
Cell ID was co-founded by Xander Sim, who is the inventor and developer of the single-use Quiz biochip PCR platform technology for testing Malaria parasitaemia, HIV viral load, and COVID-19. Quiz SARS-CoV-2 NAT uses real-time RT-LAMP, and fully meets the 95%CI accuracy standard. Cell ID obtained patent-granted status for the heating element used in the Quiz Biochip platform technology from the US Patent Office, along with patents granted by national Patent Offices in Japan, Taiwan, Africa, Indonesia, Europe, China, and Singapore.
Multicultural team of R&D, Productions, and Operations teams.
After Seed and Series A funding from ACA Investments Pte Ltd and other coinvestors.
Cell ID has been granted mote than 15 patents in 28 territories for key technologies to enable point-of-care testing
production theoretical capacity from the Highly Automated in-house assembly production line.
Milestones
2021 – Quiz Biochip COVID-19 assay is CE Marked
Quiz Sars-Cov-2 NAT test is now CE registered along with Quiz App and Poche Dongle
2019 – First Validation of Quiz Biochip Platform HIV Viral Load Assay
Results form a European reference lab show high accuracy of the Quiz platform in plasma HIV Viral Loads quantification
2018 – First patent granted for Quiz Biochip
First patent granted on the Quiz Biochip design by the US Patent Office.
2016 – RDT HIV is HSA Approved
Health Science Authority of Singapore granted approval for HIV screening test kit.
2015 – First Seed funding
ACA Investment Pte Ltd invested US $1m in Cell ID
2014 – Cell ID was founded
Xander Sim and Dr. SP Neo founded the company in Singapore
